• Home

• Small Molecules: Hit identification

• Small Molecules: Hit-to-Lead optimization

• Small Molecules: physicochemical properties

• Small Molecules: ADME

• Small Molecules: Toxicity

• Small Molecules: Selectivity

• Antibodies: Humanization and Optimization

• Protein Modeling. Discovery

• Protein Modeling: HERG binding

• Protein Modeling: Albumin binding

• Quantum Discussions Forum    

QUANTUM PHARMACEUTICALS

Quantum Pharmaceuticals is a drug design and preclinical contract research organization (CRO). We offer hit identification services, hit-to-lead programs, lead optimization services, as well as antibody optimization and humanization services. Our clients are biotech companies and scientific organizations around the world.

We focus on employing our breakthrough computational technologies and providing drug discovery services. We use our partner companies to produce chemical synthesis, in-vitro and vivo tests, and other non-computational activities.

Quantum Pharmaceuticals develops industry leading computational drug design technologies based on applying quantum, molecular and statistical physics in molecular modeling. Their applying in drug design is proved to be reliable, and provides substantial time and cost savings.

Our company also commercializes our proprietary developed drug discovery software. We have already sold our products to hundreds clients, from small research organizations to major pharmaceutical companies.

Collaborations and partnerships with research organizations and biotech companies are an essential part of the way we conduct our business. We seek organizations engaging in breakthrough work to create new medicines, where our innovative technologies can be applied. We approach our collaborations with creativity and flexibility.

Subscribe to get notifications about our new products and services by e-mail